Literature DB >> 8475949

Case report: pentamidine and polymorphic ventricular tachycardia revisited.

S Mani1, A G Kocheril, V T Andriole.   

Abstract

Pentamidine isethionate has been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases of this complication and reviews all reported cases to date. Pentamidine-induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred after an average of 10 days of treatment with pentamidine. In these patients, no other acute side effects of pentamidine were observed. Torsade de pointes can be treated when recognized early, possibly without discontinuation of pentamidine. When QTc interval prolongation is observed, early magnesium supplementation is advocated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475949     DOI: 10.1097/00000441-199304000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Adverse effects of chemotherapeutic agents used in tropical medicine.

Authors:  G C Cook
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

Review 4.  Drug-induced cardiac arrhythmias: incidence, prevention and management.

Authors:  J C Doig
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.228

Review 5.  An overview of diagnosis and management of drug-induced hypomagnesemia.

Authors:  George Liamis; Ewout J Hoorn; Matilda Florentin; Haralampos Milionis
Journal:  Pharmacol Res Perspect       Date:  2021-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.